Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 -

    Information on compound synthesis, in vitro assays, intracellular viability assay, cytotoxicity experiments, reversion of mutations, microsomal fraction stability experimental procedure and inhibition of Mtb DNA gyrase by compounds, in vivo assays, and pharmacokinetic studies.

    PDF, 241K